Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin Hypersensitivity Treatment
Launched by FEDERAL UNIVERSITY OF UBERLANDIA · Mar 14, 2017
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
Dentin hypersensitivity (DH) is characterized as a short, intense and sudden pain caused by thermal, chemical and evaporative stimuli. There are several types of desensitizing agents, used to aid in the control of this pathology, but they are not very effective and have short longevity. The agents based on potassium oxalate have been used by dental surgeons because they have mixed action, both neural and obliterating. Therefore, the aim of this study is through a triple blind randomized clinical trial (split-mouth), evaluate the longevity and efficacy of two products potassium oxalate-based...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy individuals
- • Both genres, interested in the treatment of Dentin Hypersensitivity
- • Patients with all teeth in their mouth
- • Patients who have at least three teeth with Dentin hypersensitivity in different quadrants
- • Good oral hygiene
- Exclusion Criteria:
- • Caries or unsatisfactory restorations
- • Presence of periodontal disease and or parafunctional habits
- • Cracks or enamel fractures
- • Extensive or unsatisfactory restorations
- • Recent restorations involving the labial surface
- • Pulpitis
- • Dentures
- • Orthodontics
- • Smokers
- • Pregnant women
- • Gastroesophageal disease presence
- • Uncontrolled systemic disease
- • Severe bruxism
- • Constant use of analgesic
- • Allergic response to dental products
About Federal University Of Uberlandia
The Federal University of Uberlândia (Universidade Federal de Uberlândia, UFU) is a prominent academic institution in Brazil, renowned for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, UFU leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university fosters collaboration among multidisciplinary teams, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trials, UFU aims to contribute valuable insights to the scientific community and enhance patient care both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uberlandia, Federal University Of Uberlandia, Brazil
Patients applied
Trial Officials
Paulo V Soares, DDS,MS,PHD
Principal Investigator
Federal University of Uberlandia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials